Glutathione transferase mu deficiency is not a marker for predisposition to sulphonamide toxicity

Biochem Pharmacol. 1991 Jul 15;42(3):696-8. doi: 10.1016/0006-2952(91)90334-2.

Abstract

Glutathione transferase mu activity, a marker for susceptibility to lung cancer and chemically induced cytogenetic damage, is not a predictive index for the predisposition to sulphonamide hypersensitivity reactions. However, considering the functional diversity and broad, overlapping substrate specificity of GSH-dependent enzymes, it is conceivable that an as yet unidentified deficiency in another GST isozyme or GSH-related enzyme may be a marker for sulphonamide toxicity. In addition, heterogeneity in cellular repair mechanisms and the diversity of the human immune response [22] may also contribute to the manifestation of the toxic effects of sulphonamides. Experiments are currently in progress to determine which of this myriad of variables is predominantly responsible for inter-individual susceptibility to the idiosyncratic reactions produced by these antibacterial agents.

MeSH terms

  • Adolescent
  • Adult
  • Cell Survival / drug effects
  • Child
  • Child, Preschool
  • Disease Susceptibility
  • Drug Evaluation, Preclinical
  • Drug Hypersensitivity / blood
  • Drug Hypersensitivity / etiology*
  • Glutathione Transferase / blood*
  • Glutathione Transferase / genetics
  • Humans
  • Middle Aged
  • Monocytes / drug effects*
  • Monocytes / enzymology
  • Sulfamethoxazole / pharmacology*
  • Sulfonamides / adverse effects*

Substances

  • Sulfonamides
  • Glutathione Transferase
  • Sulfamethoxazole